The AHA and three other national hospital groups today urged the Centers for Medicare & Medicaid Services to postpone the February publication of its Overall Hospital Quality Star Ratings on the Hospital Compare website.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA comments on draft report from the Office of the National Coordinator for Health Information Technology entitled “Strategy on Reducing Regulatory and Administrative Burden Relating to the Use to of Health IT and EHRs.”
AHA comments to CMS regarding proposed regulation to modernize Medicare Part D and Medicare Advantage programs to lower drug prices and reduce out-of-pocket.expenses.
Letter to the CMS expresses concern with the application deadline of February 19, 2019 for Accountable Care Organizations applying to participate in the Medicare Shared Savings Program beginning in July 2019.
AHA to MACPAC Re: Proposed Changes to the Medicaid Disproportionate Share Hospital Program Allotment
AHA comments on the Medicaid and CHIP Payment and Access Commission’s proposed recommendations related to the Medicaid Disproportionate Share Hospital program.
AHA, other health organizations express concerns with the application deadline of February 19, 2019 for Accountable Care Organizations applying to participate in the Medicare Shared Savings Program beginning July 1, 2019.
AHA letter to MedPAC regarding payment recommendations for 2020.
The AHA and the Federation of American Hospitals urge Congress to oppose any legislation that would repeal current law limiting self-referral to physician-owned hospitals.
A coalition of 40 health care and public health organizations, including the AHA urge the Senate to quickly pass the Pandemic and All-Hazards Preparedness and Advancing Innovation Act.
AHA provides feedback on the Food and Drug Administration’s request for comments on the public meeting, “Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions.